摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

二甲基苄基十六烷基氯化铵 | 10328-34-4

中文名称
二甲基苄基十六烷基氯化铵
中文别名
苄基十六烷基二甲基氯化铵水合物;N-十六烷基-N,N-二甲基苄基氯化铵;十六烷基二甲基苄基氯化铵(HDBAC);苄基-十六烷基-二甲基氯化铵;十六烷基二甲基苄基氯化铵;西他氯铵;十六烷基苄基二甲基氯化铵
英文名称
benzyldimethylhexadecylammonium cation
英文别名
Hexadecyl-dimethyl-benzyl-ammonium;Dimethyl-hexadecyl-benzyl-ammonium;Cetyl-dimethyl-benzyl-ammonium;Benzyl-cetyl-dimethylammonium;Cetalkonium;benzyl-hexadecyl-dimethylazanium
二甲基苄基十六烷基氯化铵化学式
CAS
10328-34-4
化学式
C25H46N
mdl
——
分子量
360.647
InChiKey
QDYLMAYUEZBUFO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    71.5-72.5 °C
  • 溶解度:
    8.5 g/L
  • 碰撞截面:
    214.8 Ų [M]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

计算性质

  • 辛醇/水分配系数(LogP):
    9.5
  • 重原子数:
    26
  • 可旋转键数:
    17
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.76
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

ADMET

代谢
由于西他克林不被吸收,这一药代动力学特性与此无关。
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
来源:DrugBank
毒理性
  • 蛋白质结合
由于庚甲锡不吸收,这一药代动力学特性与此无关。
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
来源:DrugBank
吸收、分配和排泄
  • 吸收
Cetalkonium主要用于局部外用,不会被吸收。当口服和静脉注射时,可能会发生Cetalkonium的吸收,但非常微不足道。
Cetalkonium is used mainly topically and it is not absorbed. When administered orally and parenterally, cetalkonium absorption may happen but it is very insignificant.
来源:DrugBank
吸收、分配和排泄
  • 消除途径
由于西他克林不被吸收,这一药代动力学特性与此无关。当口服给药时,大部分给药剂量以原形在粪便中排泄,因为它吸收非常差。
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant. When administered orally, most of the administered dose is excreted unchanged in the feces as it is very poorly absorbed.
来源:DrugBank
吸收、分配和排泄
  • 分布容积
由于西他克林不被吸收,这一药代动力学特性与此无关。
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
来源:DrugBank
吸收、分配和排泄
  • 清除
由于西他克林不被吸收,这一药代动力学特性与此无关。
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
来源:DrugBank

文献信息

  • PROCESS FOR PRODUCING 1,1-DICHLORO-2,3,3,3-TETRAFLUOROPROPENE AND 2,3,3,3-TETRAFLUOROPROPENE
    申请人:SEKI Ryuji
    公开号:US20110319678A1
    公开(公告)日:2011-12-29
    To provide a process to produce 1,1-dichloro-2,3,3,3-tetrafluoropropene (CFO-1214ya) simply and economically without requiring purification of 1,1-dichloro-2,2,3,3,3-pentafluoropropane (HCFC-225ca) from the raw material component obtained as a mixture of isomers, i.e. dichloropentafluoropropane (HCFC-225) including HCFC-225ca and at the same time to produce simply and economically 2,3,3,3-tetrafluoropropene (HFO-1234yf) from 1-chloro-2,3,3,3-tetrafluoropropane (HCFC-244eb). A raw material composition comprising HCFC-244eb and HCFC-225 including HCFC-225ca is contacted with an alkali aqueous solution in the presence of a phase-transfer catalyst to produce CFO-1214ya from HCFC-225ca and at the same time to produce HFO-1234yf from HCFC-244eb.
    提供一种简单经济的方法来生产1,1-二氯-2,3,3,3-四氟丙烯(CFO-1214ya),无需从作为异构体混合物获得的原料组分中纯化1,1-二氯-2,2,3,3,3-五氟丙烷(HCFC-225ca),即二氯五氟丙烷(HCFC-225)包括HCFC-225ca,并同时简单经济地生产2,3,3,3-四氟丙烯(HFO-1234yf)从1-氯-2,3,3,3-四氟丙烷(HCFC-244eb)。 将包括HCFC-244eb和HCFC-225的原料组合物与相转移催化剂存在的碱性水溶液接触,从HCFC-225ca产生CFO-1214ya,同时从HCFC-244eb产生HFO-1234yf。
  • MANUFACTURING METHOD OF 1-CHLORO-2,3,3,3-TETRAFLUOROPROPENE
    申请人:ASAHI GLASS COMPANY, LIMITED
    公开号:US20180297918A1
    公开(公告)日:2018-10-18
    There is provided an economically advantageous manufacturing method capable of efficiently obtaining 1-chloro-2,3,3,3-tetrafluoropropene by using 1,2-dichloro-2,3,3,3-tetrafluoropropane as a raw material. A manufacturing method of 1-chloro-2,3,3,3-tetrafluoropropene is characterized in that it includes subjecting 1,2-dichloro-2,3,3,3-tetrafluoropropane to a dehydrochlorination reaction in a liquid phase in a presence of a base.
    提供了一种经济优势的制造方法,能够有效地利用1,2-二氯-2,3,3,3-四氟丙烷作为原料,高效地获得1-氯-2,3,3,3-四氟丙烯。1-氯-2,3,3,3-四氟丙烯的制造方法的特点在于,它包括在碱的存在下将1,2-二氯-2,3,3,3-四氟丙烷在液相中进行脱氯化反应。
  • Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients
    申请人:Rogers D. Robin
    公开号:US20070093462A1
    公开(公告)日:2007-04-26
    Disclosed are ionic liquids and methods of preparing ionic liquid compositions of active pharmaceutical, biological, nutritional, and energetic ingredients. Also disclosed are methods of using the compositions described herein to overcome polymorphism, overcome solubility and delivery problems, to control release rates, add functionality, enhance efficacy (synergy), and improve ease of use and manufacture.
    揭示了离子液体及制备活性药物、生物、营养和能量成分的离子液体组合物的方法。还揭示了利用本文描述的组合物的方法,以克服多型性、克服溶解度和输送问题、控制释放速率、增加功能性、增强功效(协同作用)以及改善易用性和制造工艺。
  • [EN] 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES AS CORROSION INHIBITORS<br/>[FR] DÉRIVÉS DE 2-MERCAPTOBENZIMIDAZOLE UTILISÉS EN TANT QU'INHIBITEURS DE CORROSION
    申请人:ECOLAB USA INC
    公开号:WO2017192514A1
    公开(公告)日:2017-11-09
    The present invention generally relates to methods and compounds for preventing metal corrosion. More specifically, the method comprises contacting a hydrocarbon-containing liquid with a composition in an effective amount to prevent metal corrosion.
    本发明一般涉及用于预防金属腐蚀的方法和化合物。更具体地,该方法包括将含碳氢化合物的液体与一种成分接触,以有效防止金属腐蚀。
  • COMPOSITIONS OF HETEROCYCLIC COMPOUNDS AND USES AS SULFIDOGENESIS INHIBITORS
    申请人:ChampionX USA Inc.
    公开号:US20210238068A1
    公开(公告)日:2021-08-05
    The present disclosure generally relates to compositions and uses of sulfidogenesis inhibitor compounds of Formulae 1 and 2 for preventing sulfidogenesis, i.e., the reduction reaction of a sulfur-containing compound by sulfur-utilizing prokaryotes that produce sulfide species such as hydrogen sulfide, during enhanced oil recovery processes. A method for inhibiting or decreasing microbial sulfide production by sulfur-utilizing prokaryotes includes addition of an effective amount of sulfidogenesis inhibitor compounds of Formulae 1 and 2 to the fluid that is injected into a sulfidogenic reservoir system during enhanced oil recovery. For example, the compounds can be used as sulfidogenesis inhibitors in a water injection system for use in a hydrocarbon extraction system or a hydrocarbon production system. Thus, these compositions can be effectively used as inhibitors of biogenic hydrogen sulfide generation in oilfield fluids.
    本公开涉及一般与化合物的组成和用途有关,化合物的化学式为1和2,用于预防硫化作用,即硫利用原核生物通过还原反应将含硫化合物还原为产生硫化氢等硫化物种的过程,在增强油田开采过程中。通过向在增强油田开采过程中注入的流体中添加化合物的有效量来抑制或减少硫利用原核生物产生的微生物硫化物的方法包括将化合物的有效量添加到硫化作用储层系统中。例如,这些化合物可以作为硫化作用抑制剂在水注入系统中使用,用于烃类萃取系统或烃类生产系统。因此,这些组成物可以有效地用作油田流体中生物源硫化氢生成的抑制剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐